Equities Research Analysts’ Ratings Reiterations for October 26th (BARC, BPOP, CGS, DERM, FCNCA, GOSS, IMCR, MCD, MSFT, OXB)

Equities Research Analysts’ ratings reiterations for Monday, October 26th:

Barclays (LON:BARC) had its buy rating reiterated by analysts at Jefferies Financial Group. Jefferies Financial Group currently has a GBX 600 target price on the stock.

Popular (NASDAQ:BPOP) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $190.00 price target on the stock, down from their previous price target of $198.00.

Castings (LON:CGS) had its buy rating reissued by analysts at Canaccord Genuity Group. The firm currently has a GBX 390 price target on the stock.

Journey Medical (NASDAQ:DERM) had its buy rating reissued by analysts at HC Wainwright. They currently have a $13.00 price target on the stock.

First Citizens BancShares (NASDAQ:FCNCA) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $2,200.00 price target on the stock, down from their previous price target of $2,300.00.

Gossamer Bio (NASDAQ:GOSS) had its buy rating reaffirmed by analysts at Chardan Capital.

Immunocore (NASDAQ:IMCR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $100.00 price target on the stock.

McDonald’s (NYSE:MCD) had its buy rating reissued by analysts at BTIG Research. They currently have a $295.00 target price on the stock.

Microsoft (NASDAQ:MSFT) had its buy rating reissued by analysts at Truist Financial. They currently have a $600.00 price target on the stock, up from their previous price target of $575.00.

Oxford Biomedica (LON:OXB) had its buy rating reiterated by analysts at Jefferies Financial Group. Jefferies Financial Group currently has a GBX 827 price target on the stock.

Prudential (LON:PRU) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 1,445 target price on the stock.

Serina Therapeutics (NYSEAMERICAN:SER) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $8.00 price target on the stock.

SL Green Realty (NYSE:SLG) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $62.00 target price on the stock, down from their previous target price of $64.00.

Tempus AI (NASDAQ:TEM) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $80.00 price target on the stock.

Unite Group (LON:UTG) had its hold rating reiterated by analysts at Jefferies Financial Group. Jefferies Financial Group currently has a GBX 450 price target on the stock.

Block (NYSE:XYZ) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $80.00 price target on the stock, down from their previous price target of $90.00.